An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking

D. Di Carlo; M. Annereau; I. Yoldjian; G. Vassal; J. Grill

doi:10.1016/j.annonc.2023.06.012

An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking

D. Di Carlo, M. Annereau, I. Yoldjian, G. Vassal, J. Grill

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

2 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	826-827
Nombre de pages	2
journal	Annals of Oncology
Volume	34
Numéro de publication	9
Les DOIs	https://doi.org/10.1016/j.annonc.2023.06.012
état	Publié - 1 sept. 2023

Accès au document

10.1016/j.annonc.2023.06.012

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{567ba11623e145c699a684cd17afcc44,

title = "An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking",

author = "{Di Carlo}, D. and M. Annereau and I. Yoldjian and G. Vassal and J. Grill",

note = "Funding Information: None declared. The authors have declared no conflicts of interest.",

year = "2023",

month = sep,

day = "1",

doi = "10.1016/j.annonc.2023.06.012",

language = "English",

volume = "34",

pages = "826--827",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "9",

}

An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma: a new way to access innovation when clinical trials are lacking. / Di Carlo, D.; Annereau, M.; Yoldjian, I. et al.
Dans: Annals of Oncology, Vol 34, Numéro 9, 01.09.2023, p. 826-827.

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

TY - JOUR

T1 - An academia-driven compassionate use program for patients with recurrent H3K27-altered diffuse midline glioma

T2 - a new way to access innovation when clinical trials are lacking

AU - Di Carlo, D.

AU - Annereau, M.

AU - Yoldjian, I.

AU - Vassal, G.

AU - Grill, J.

N1 - Funding Information: None declared. The authors have declared no conflicts of interest.

PY - 2023/9/1

Y1 - 2023/9/1

UR - http://www.scopus.com/inward/record.url?scp=85168428645&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2023.06.012

DO - 10.1016/j.annonc.2023.06.012

M3 - Letter

C2 - 37423297

AN - SCOPUS:85168428645

SN - 0923-7534

VL - 34

SP - 826

EP - 827

JO - Annals of Oncology

JF - Annals of Oncology

IS - 9

ER -